MURDOCK TERRY L

CIK 00012740711 companyRESEARCH TRIANGLE PARK, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001274071

Recent Transactions

45 trades

Disposition from Tender
G1 Therapeutics, Inc.
Common Stock
2024-09-18−21,150→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−74,500→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−35,700→ 0 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-09-18+17,900→ 145,912 total
Disposition to Issuer
G1 Therapeutics, Inc.
Common Stock
2024-09-18−124,762→ 21,150 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-07-05$2.51/sh−2,475→ 128,012 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-07-01+35,000→ 130,487 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-05-13$4.79/sh−8,151→ 95,487 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-04$2.94/sh−721→ 103,638 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-01-03+37,300→ 107,378 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−758→ 106,620 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2024-01-03+74,500→ 74,500 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−2,261→ 104,359 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-07-05$2.45/sh−1,361→ 70,078 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-05-10+35,000→ 71,439 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-01-05$5.41/sh−729→ 36,439 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-01-04$5.58/sh−1,639→ 37,168 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2023-01-03+35,700→ 35,700 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-01-03+17,900→ 38,807 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-07-05$5.17/sh−648→ 20,907 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-01-05$10.61/sh−1,445→ 21,555 total
Award
G1 Therapeutics, Inc.
Common Stock
2022-01-03+12,000→ 23,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2022-01-03+53,000→ 53,000 total
Award
G1 Therapeutics, Inc.
Common Stock
2021-01-04+11,000→ 11,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-01-04+58,000→ 58,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2020-02-06+60,000→ 60,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2019-01-02+60,000→ 60,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-12-03−3,523→ 82,401 total
Sale
G1 Therapeutics, Inc.
Common Stock
2018-12-03$38.54/sh−3,523→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-12-03$13.51/sh+3,523→ 3,523 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-11-05$13.51/sh+3,519→ 3,519 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-11-05−3,519→ 85,924 total
Sale
G1 Therapeutics, Inc.
Common Stock
2018-11-05$41.53/sh−3,519→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-10-03−3,519→ 89,443 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-10-03$13.51/sh+3,519→ 3,519 total
Sale
G1 Therapeutics, Inc.
Common Stock
2018-10-03$49.18/sh−3,519→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-09-04−3,519→ 92,962 total
Sale
G1 Therapeutics, Inc.
Common Stock
2018-09-04$59.98/sh−3,519→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-09-04$13.51/sh+3,519→ 3,519 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-08-03$13.51/sh+3,519→ 3,519 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-08-03−3,519→ 96,481 total
Sale
G1 Therapeutics, Inc.
Common Stock
2018-08-03$50.60/sh−3,519→ 0 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-06-01+50,000→ 50,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-01-02+50,000→ 50,000 total
Award
G1 Therapeutics, Inc.
Stock option (right to buy)
2017-08-01+100,000→ 100,000 total

Companies

G1 Therapeutics, Inc.
SVP of Development Operations

Recent Filings

Address

79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100

RESEARCH TRIANGLE PARK, NC, 27709

View on SEC.gov